Sign in
Not yet recruitingNo phase

Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery

Key facts

Who runs it
University of British Columbia
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
60 people, planned
Started
Sept 2025
Expected to end
Jan 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • A novel device developed providing nature-driven responsive imagery that responds to the patient's physiological to distract, engage, and de-escalate behaviours of delirium.
  • Routine post-operative management and standard delirium reduction measures.
Record updated
3 July 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Planned open-heart cardiac surgery (e.g. coronary artery bypass grafting, valve replacement surgery)
  • Able to understand study procedures and provide informed consent in English
  • At least one delirium risk factor: 1) Age less than 65yrs; 2) History of delirium; 3) History of stroke/TIA; 4) Known cognitive impairment; 5) Depression requiring medication

Who cannot take part

  • Severe pre-existing cognitive impairment (Montreal Cognitive Assessment [MOCA6]<10)
  • Uncorrected visual impairment
  • Significant impairment from psychiatric disease
  • Enrolment in another clinical trial which may interfere with the study outcome measures

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if a novel device (MindfulGarden) is beneficial in a population of patients undergoing cardiac surgery. The main questions it aims to answer are:

Read full original descriptionShow less

Is a novel device (MindfulGarden) that uses responsive nature-driven imagery feasible in patients undergoing cardiac surgery? Will use of this device reduce the use of psychotropic medications, improve recovery experience, and improve delirium?

Participants will receive routine post-operative management and standard delirium reduction measures. They will be randomized into two groups where one receives the novel device (MindfulGarden) and the other does not.

The 2 groups in the trial

  • Intervention GroupTreatment being tested

    Receives the MindfulGarden intervention in addition to routine post-operative management and standard delirium reduction measures.

    Treatment: A novel device developed providing nature-driven responsive imagery that responds to the patient's physiological to distract, engage, and de-escalate behaviours of delirium.

  • Control GroupExisting treatment, for comparison

    Participants will receive standard care, which includes routine post-operative care pathways for cardiac surgery, and standard delirium reduction measures.

    Treatment: Routine post-operative management and standard delirium reduction measures.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery: A Pilot Randomized Controlled Trial
Record updated
3 July 2025